← back to search

Íngrid Ordás

Hospital Universitari Arnau de Vilanova ·
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Autoimmune and Inflammatory Disorders, and Gastrointestinal Bleeding Diagnosis and Treatment.
h-index
42
citations
11,967
works
215
NIH funding
primary concept
Medicine
email

Recent publications

Comparison of Conventional versus Abbreviated MR Enterography: Assessing Disease Activity and Complications in Crohn Disease.
2026cited by 0position: contributordoi
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.
2026cited by 0position: contributordoi
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis.
2026cited by 0position: contributordoi
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU.
2025cited by 4position: contributordoi
TL1A-activated T cells remodel the rectal mucosa in patients with Crohn's disease with perianal fistulising disease.
2025cited by 0position: contributordoi
The CROCO (CROhn's Disease COhort Study) - study design and protocol.
2025cited by 0position: contributordoi
TL1A-activated T cells remodel the rectal mucosa in Crohn’s disease patients with perianal fistulizing disease
2025cited by 0position: contributordoi
New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicity
Biomedicine & Pharmacotherapy 2025cited by 0position: contributordoi
Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's disease.
2024cited by 8position: contributordoi
Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the <i>AJR</i> Special Series on Imaging of Fibrosis.
2024cited by 8position: contributordoi
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
2023cited by 29position: contributordoi
Experimental evidence of effective human-AI collaboration in medical decision-making.
2022cited by 72position: contributordoi
A novel AI device for real-time optical characterization of colorectal polyps
npj Digital Medicine 2022cited by 44position: contributordoi
Avoiding contrast-enhanced sequences does not compromise the precision of the simplified MaRIA for the assessment of non-penetrating Crohn's disease activity.
2022cited by 11position: contributordoi
Fecal Calprotectin for Small Bowel Crohn's Disease: Is It a Cutoff Issue?
2022cited by 11position: contributordoi
Experimental and genetic evidence for the impact of <i>CD5</i> and <i>CD6</i> expression and variation in inflammatory bowel disease.
2022cited by 9position: contributordoi
Predictors of bowel damage in the long-term progression of Crohn's disease.
2022cited by 4position: contributordoi
Author Correction: A novel AI device for real-time optical characterization of colorectal polyps.
2022cited by 2position: contributordoi
Dissecting Common and Unique Effects of Anti-α4β7 and Anti-Tumor Necrosis Factor Treatment in Ulcerative Colitis.
2021cited by 22position: contributordoi
Letter: accuracy of magnetic resonance index of activity score to predict response to biologics in Crohn's disease-authors' reply.
2021cited by 0position: contributordoi
Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn’s Disease
Journal of Crohn's and Colitis 2020cited by 38position: contributordoi
Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease.
2020cited by 33position: contributordoi
Variation in Colonoscopy Performance Measures According to Procedure Indication.
2020cited by 21position: contributordoi
Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.
2020cited by 11position: contributordoi
Is endoscopic treatment of small bowel strictures effective and safe in patients with Crohn's disease?
2020cited by 2position: contributordoi
Successful management of refractory immune-mediated enterocolitis with cyclosporine.
2020cited by 1position: contributordoi
Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s Disease
Gastroenterology 2019cited by 195position: contributordoi
Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
2019cited by 4position: contributordoi
Reliability of Measuring Ileo-Colonic Disease Activity in Crohn’s Disease by Magnetic Resonance Enterography
Inflammatory Bowel Diseases 2018cited by 67position: middledoi
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis
Gut 2016cited by 205position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jordi Rimola · Hospital Clínic de Barcelona11 papers (2019–2026) · 10 papers (2019–2026)Maria Esteve · Instituto de Salud Carlos III5 papers (2020–2025)Julian Panés · University College London5 papers (2019–2025)Agnès Fernández-Clotet · Hospital Clínic de Barcelona4 papers (2022–2026)Jordi Guardiola · Merrion Fertility Clinic4 papers (2020–2025)William J. Sandborn · Mirati Therapeutics (United States)4 papers (2012–2018)Luis Bujanda · Ikerbasque3 papers (2020–2023)Andrea Cherubini · Cosmo Pharmaceuticals (Ireland)3 papers (2022–2022)Mario Dinis-Ribeiro · Instituto Português de Oncologia Francisco Gentil3 papers (2022–2022)Julián Panés · Instituto de Salud Carlos III3 papers (2015–2018) · 2 papers (2022–2022)Carlo Biffi · Institute of Group Analysis2 papers (2022–2022)Anthony Buisson · Centre Hospitalier Universitaire de Clermont-Ferrand2 papers (2023–2025)Albert Martín‐Cardona · Instituto de Salud Carlos III2 papers (2025–2025)Berta Caballol · Universitat de Barcelona2 papers (2022–2025)Victoria Gudino · Institut d'Investigacions Biomèdiques de Barcelona2 papers (2025–2025)Raquel Franco-Leal · Universidade Estadual de Campinas (UNICAMP)2 papers (2025–2025)Azucena Salas · Universitat de Barcelona2 papers (2025–2025)Johan Burisch · Rigshospitalet2 papers (2023–2025)